Abstract
For children aged 5–17 years, 100 mg or less of chlorpromazine equivalents was not associated with increased risk of death, but for doses greater than 100 mg, young adults aged 18–24 years had significantly increased risk of death, according to a study published online November 29, 2023 in JAMA Psychiatry. The conclusion — that mortality from antipsychotic medications is related to the dose — applies to children as well as young adults — the researchers said.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child & Adolescent Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
